Back
Rhythm Pharmaceuticals Vs. Moderna Industry Stock Comparison
Buy
57
RYTM
Rhythm Pharmaceuticals
Last Price:
$56.05
Seasonality Move:
-14.94%
Sell
6
MRNA
Moderna
Last Price:
$39.44
Seasonality Move:
9.23%
Buy
57
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $56.12. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $56.12The current trend is relatively stagnant and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 46.95 | Sell |
Chaikin Money Flow: | -727729 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.98 - 60.64) | Sell |
Bollinger Bands (100): | (46.41 - 57.91) | Buy |
MRNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.88 | Sell |
Relative Strength Index (14 RSI): | 39.16 | Sell |
Chaikin Money Flow: | -23965526 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.9 - 43.7) | Sell |
Bollinger Bands (100): | (44.03 - 78.35) | Sell |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 55.68 | Buy |
20-day SMA: | 58.24 | Sell |
50-day SMA: | 56.08 | Buy |
200-day SMA: | 46.9 | Buy |
8-day EMA: | 56.02 | Buy |
20-day EMA: | 57.1 | Sell |
50-day EMA: | 56 | Buy |
200-day EMA: | 48.16 | Buy |
MRNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.93 | Sell |
20-day SMA: | 42.19 | Sell |
50-day SMA: | 46.77 | Sell |
200-day SMA: | 91.53 | Sell |
8-day EMA: | 40.57 | Sell |
20-day EMA: | 42.05 | Sell |
50-day EMA: | 48.52 | Sell |
200-day EMA: | 78.87 | Sell |
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.77 per share.
Moderna Earnings Growth & MRNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.74 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.24 per share, and an increase next year of $0.36 per share.
Rhythm Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Moderna Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |